165 related articles for article (PubMed ID: 24885673)
1. Effectiveness of the Dader Method for pharmaceutical care in patients with bipolar I disorder: EMDADER-TAB: study protocol for a randomized controlled trial.
Salazar-Ospina A; Amariles P; Benjumea DM; Gutierrez F; Faus MJ; Rodriguez LF
Trials; 2014 May; 15():174. PubMed ID: 24885673
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of the Dader Method for Pharmaceutical Care on Patients with Bipolar I Disorder: Results from the EMDADER-TAB Study.
Salazar-Ospina A; Amariles P; Hincapié-García JA; González-Avendaño S; Benjumea DM; Faus MJ; Rodriguez LF
J Manag Care Spec Pharm; 2017 Jan; 23(1):74-84. PubMed ID: 28025928
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Dader Method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV randomized controlled trial.
Amariles P; Sabater-Hernández D; García-Jiménez E; Rodríguez-Chamorro MÁ; Prats-Más R; Marín-Magán F; Galán-Ceballos JA; Jiménez-Martín J; Faus MJ
J Manag Care Pharm; 2012 May; 18(4):311-23. PubMed ID: 22548691
[TBL] [Abstract][Full Text] [Related]
4. Long-term impact of pharmacist intervention in patients with bipolar disorder: extended follow-up to the EMDADER-TAB study.
Salazar-Ospina A; Amariles P; Hincapié-García JA; González-Avendaño S
Heliyon; 2020 Feb; 6(2):e03333. PubMed ID: 32072044
[TBL] [Abstract][Full Text] [Related]
5. Effect and associated factors of a clinical pharmacy model in the incidence of medication errors (EACPharModel) in the Hospital Pablo Tobón Uribe: study protocol for a stepped wedge randomized controlled trial (NCT03338725).
Granados J; Salazar-Ospina A; Botero-Aguirre JP; Valencia-Quintero AF; Ortiz N; Amariles P
Trials; 2020 Jan; 21(1):26. PubMed ID: 31907009
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of pharmaceutical care for drug treatment adherence in patients with systemic lupus erythematosus in Rio de Janeiro, Brazil: study protocol for a randomized controlled trial.
Oliveira-Santos M; Verani JF; Camacho LA; de Andrade CA; Ferrante-Silva R; Klumb EM
Trials; 2016 Apr; 17():181. PubMed ID: 27038611
[TBL] [Abstract][Full Text] [Related]
7. The addition of STEPPS in the treatment of patients with bipolar disorder and comorbid borderline personality features: a protocol for a randomized controlled trial.
Riemann G; Weisscher N; Goossens PJ; Draijer N; Apenhorst-Hol M; Kupka RW
BMC Psychiatry; 2014 Jun; 14():172. PubMed ID: 24912456
[TBL] [Abstract][Full Text] [Related]
8. Eye movement desensitization and reprocessing therapy versus supportive therapy in affective relapse prevention in bipolar patients with a history of trauma: study protocol for a randomized controlled trial.
Moreno-Alcázar A; Radua J; Landín-Romero R; Blanco L; Madre M; Reinares M; Comes M; Jiménez E; Crespo JM; Vieta E; Pérez V; Novo P; Doñate M; Cortizo R; Valiente-Gómez A; Lupo W; McKenna PJ; Pomarol-Clotet E; Amann BL
Trials; 2017 Apr; 18(1):160. PubMed ID: 28376919
[TBL] [Abstract][Full Text] [Related]
9. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
10. Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness.
Valenstein M; Kavanagh J; Lee T; Reilly P; Dalack GW; Grabowski J; Smelson D; Ronis DL; Ganoczy D; Woltmann E; Metreger T; Wolschon P; Jensen A; Poddig B; Blow FC
Schizophr Bull; 2011 Jul; 37(4):727-36. PubMed ID: 19933540
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of smartphone-based ambulatory assessment (SBAA-BD) including a predicting system for upcoming episodes in the long-term treatment of patients with bipolar disorders: study protocol for a randomized controlled single-blind trial.
Mühlbauer E; Bauer M; Ebner-Priemer U; Ritter P; Hill H; Beier F; Kleindienst N; Severus E
BMC Psychiatry; 2018 Oct; 18(1):349. PubMed ID: 30367608
[TBL] [Abstract][Full Text] [Related]
12. B-positive: a randomized controlled trial of a multicomponent positive psychology intervention for euthymic patients with bipolar disorder - study protocol and intervention development.
Kraiss JT; Ten Klooster PM; Chrispijn M; Trompetter HR; Stevens AWMM; Neutel E; Kupka RW; Bohlmeijer ET
BMC Psychiatry; 2018 Oct; 18(1):335. PubMed ID: 30333004
[TBL] [Abstract][Full Text] [Related]
13. Effect of medication review and cognitive behaviour treatment by community pharmacists of patients discharged from the hospital on drug related problems and compliance: design of a randomized controlled trial.
Ahmad A; Hugtenburg J; Welschen LM; Dekker JM; Nijpels G
BMC Public Health; 2010 Mar; 10():133. PubMed ID: 20230611
[TBL] [Abstract][Full Text] [Related]
14. Misdiagnosis, duration of untreated illness (DUI) and outcome in bipolar patients with psychotic symptoms: A naturalistic study.
Altamura AC; Buoli M; Caldiroli A; Caron L; Cumerlato Melter C; Dobrea C; Cigliobianco M; Zanelli Quarantini F
J Affect Disord; 2015 Aug; 182():70-5. PubMed ID: 25978716
[TBL] [Abstract][Full Text] [Related]
15. Enhancing adherence to antipsychotic treatment for bipolar disorders. Comparison of mobile app-based psychoeducation, group psychoeducation, and the combination of both: protocol of a three-arm single-blinded parallel-group multi-centre randomised trial.
Pozza A; Coluccia A; Gualtieri G; Ferretti F
Clin Ter; 2020; 171(2):e7-e93. PubMed ID: 32141476
[TBL] [Abstract][Full Text] [Related]
16. Cognitive-behavioral rehabilitation vs. treatment as usual for bipolar patients: study protocol for a randomized controlled trial.
Gomes BC; Rocca CC; Belizario GO; Lafer B
Trials; 2017 Mar; 18(1):142. PubMed ID: 28351410
[TBL] [Abstract][Full Text] [Related]
17. A 6-Month, Prospective, Randomized Controlled Trial of Customized Adherence Enhancement Versus Bipolar-Specific Educational Control in Poorly Adherent Individuals With Bipolar Disorder.
Sajatovic M; Tatsuoka C; Cassidy KA; Klein PJ; Fuentes-Casiano E; Cage J; Aebi ME; Ramirez LF; Blixen C; Perzynski AT; Bauer MS; Safren SA; Levin JB
J Clin Psychiatry; 2018 Sep; 79(6):. PubMed ID: 30256551
[TBL] [Abstract][Full Text] [Related]
18. Daily electronic monitoring of subjective and objective measures of illness activity in bipolar disorder using smartphones--the MONARCA II trial protocol: a randomized controlled single-blind parallel-group trial.
Faurholt-Jepsen M; Vinberg M; Frost M; Christensen EM; Bardram J; Kessing LV
BMC Psychiatry; 2014 Nov; 14():309. PubMed ID: 25420431
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of sulforaphane as an adjuvant in the treatment of bipolar depressive disorder: Study protocol for a randomized, double-blinded, placebo-controlled, parallel-group clinical trial.
Wu C; Chen X; Lai J; Xu Y; Hu S
Medicine (Baltimore); 2020 Jun; 99(26):e20981. PubMed ID: 32590809
[TBL] [Abstract][Full Text] [Related]
20. Collaborative care for patients with bipolar disorder: a randomised controlled trial.
van der Voort TY; van Meijel B; Goossens PJ; Renes J; Beekman AT; Kupka RW
BMC Psychiatry; 2011 Aug; 11():133. PubMed ID: 21849078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
